UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,425.20 -13.30 (-0.55%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,713.19 +332.79 (+0.61%)
OMER Jun 2024 4.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:19PM EDT. Market open.
| Previous close | 0.1100 |
| Open | 0.1000 |
| Bid | 0.0500 |
| Ask | 0.1500 |
| Strike | 4.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1000 - 0.1300 |
| Contract range | N/A |
| Volume | |
| Open interest | 469 |
- GuruFocus.com
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
Amidst a significant net loss increase, Omeros Corp navigates through promising drug trials and strategic royalty milestones.
Business WireOmeros Corporation Reports First Quarter 2024 Financial Results
SEATTLE, May 15, 2024--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders, today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2024, which include:
© 2024 Yahoo. All rights reserved.